✦ LIBER ✦

Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes

✍ Scribed by M. Flint Beal; Michael F. Mazurek; Joseph B. Martin

Book ID: 115796691
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 271 KB
Volume: 397
Category: Article
ISSN: 0006-8993
DOI: 10.1016/0006-8993(86)90644-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatostatin and neuropeptide Y immunore

Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes

✍ M. Flint Beal; Ross A. Clevens; Michael F. Mazurek 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Somatostatin-281–12-like immunoreactivit

Somatostatin-281–12-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex

✍ M. Flint Beal; Robert Benoit; Michael F. Mazurek; Edward D. Bird; Joseph B. Mart 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Galanin-Like Immunoreactivity Is Unchang

Galanin-Like Immunoreactivity Is Unchanged in Alzheimer's Disease and Parkinson's Disease Dementia Cerebral Cortex

✍ M. Flint Beal; Ross A. Clevens; Geetinder K. Chattha; Usha M. MacGarvey; Michael 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

Somatostatin and dementia in Parkinson's

Somatostatin and dementia in Parkinson's disease

✍ Jacques Epelbaum; Merle Ruberg; Emmanuel Moyse; France Javoy-Agid; Bruno Dubois; 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 263 KB

SPECT findings in Alzheimer's disease an

SPECT findings in Alzheimer's disease and Parkinson's disease with dementia

✍ S. E. Starkstein; S. Vázquez; G. Petracca; L Sabe; M. Merello; R. Leiguarda 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Pentagon drawing and neuropsychological

Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia

✍ Francesca Cormack; Dag Aarsland; Clive Ballard; Martin J. Tovée 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio